Literature DB >> 3299896

Failure of malaria chemoprophylaxis with a proguanil-chloroquine combination in Papua New Guinea.

A Henderson, J W Simon, W Melia.   

Abstract

Proguanil 200 mg daily and chloroquine base 300 mg weekly were used as prophylaxis for 120 British Army soldiers from Hong Kong on a seven-week jungle exercise in the highly malarious Sepik district of Papua New Guinea. Compliance was rigidly enforced. Four men developed falciparum malaria whilst in Papua New Guinea and one within a few days of returning to Hong Kong. After stopping chloroquine four weeks after returning to Hong Kong 11 cases of mixed vivax and falciparum malaria and three cases of falciparum alone occurred within a 16-week period. This proguanil-chloroquine combination allows an unacceptably high level of breakthrough malaria and cannot be recommended for visitors to the highly malarious areas of Papua New Guinea.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3299896     DOI: 10.1016/0035-9203(86)90398-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

Review 1.  Prevention of malaria in travellers: a growing problem.

Authors:  J S Keystone; J D MacLean
Journal:  CMAJ       Date:  1989-11-15       Impact factor: 8.262

Review 2.  Antimalarial agents: specific chemoprophylaxis regimens.

Authors:  B L Herwaldt; D J Krogstad; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 3.  Efficacy of drug prophylaxis.

Authors:  P A Phillips-Howard
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

Review 4.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

5.  Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.

Authors:  S Fogh; A Schapira; I C Bygbjerg; S Jepsen; C H Mordhorst; K Kuijlen; P Ravn; A Rønn; P C Gøtzsche
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.